• Asian-Australasian Journal of Animal Sciences
• /
• 제25권5호
• /
• pp.606-612
• /
• 2012

Insulin-like growth factor-binding protein-5 (IGFBP-5) is one of the six members of IGFBP family, important for cell growth, apoptosis and other IGF-stimulated signaling pathways. In order to explore the significance of IGFBP-5 in cells of the Inner Mongolian Cashmere goat (Capra hircus), IGFBP-5 gene complementary DNA (cDNA) was amplified by reverse transcription polymerase chain reaction (RT-PCR) from the animal's fetal fibroblasts and tissue-specific expression analysis was performed by semi-quantitative RT-PCR. The gene is 816 base pairs (bp) in length and includes the complete open reading frame, encoding 271 amino acids (GenBank accession number JF720883). The full cDNA nucleotide sequence has a 99% identity with sheep, 98% with cattle and 95% with human. The amino acids sequence shares identity with 99%, 99% and 99%, respectively. The bioinformatics analysis showed that IGFBP-5 has an insulin growth factor-binding protein homologues (IB) domain and a thyroglobulin type-1 (TY) domain, four protein kinase C phosphorylation sites, five casein kinase II phosphorylation sites, three prenyl group binding sites (CaaX box). The IGFBP-5 gene was expressed in all the tested tissues including testis, brain, liver, lung, mammary gland, spleen, and kidney, suggesting that IGFBP-5 plays an important role in goat cells.

• 보험의학회지
• /
• 제1권1호
• /
• pp.123-132
• /
• 1984

Among the person who want to insure, there are not only fair persons who want to become the insurance with not realizing that one was not infected with certain disease but also someones on purpose to overcome the disease through the insurance company with be recognized by oneselves. However, it was found that the ultrasonography and exact effects of medical examination with the existing medical equipments of the insurance company could not be expected. We present some several proven examples for the purpose of getting the advanced effects in medical examination by utilizing the ultrasonic device which is not harmful to human body presently as far as known. We could find affirmation through the check of ultrasonography from 907 cases, in our Department of Medical selection that many portion of the cases checked the medical examination have the present condition of illness even though they enjoy social life with good health and finally the conclusions we have learned are as follows; The aged cases show the increase of rate of possessing disease and man shows 2.2 times of possessing disease than woman. Fatty infiltration of liver take portion of 74.7% from the case checked. 12 cases of cholelithiasis are not conscious of symptom at all. Through the check of ultrasonography in obstetrics and gynecology, myoma uteri be showed high rate of 72.2% from the case of possessing disease. In Case of the potential pregnancing woman it made clear to find pregnancy which was undistincted still more also know the existence and nonexistence of fetal death when pregnancy expected.

• BMB Reports
• /
• 제34권4호
• /
• pp.316-321
• /
• 2001

Dehydroascorbate (DHA) reductase (DHAR, EC 1.8.5.1) catalyzes the reduction of DHA to reduced ascorbate (AsA) using glutathione (GSH) as the electron donor in order to maintain an appropriate level of ascorbate in plant cells. To analyze the physiological role of DHAR in environmental stress adaptation, we developed transgenic tobacco (Nicotiana tabacum cv. Xanthi) plants that express a human DHAR gene isolated from the human fetal liver cDNA library in the chloroplasts. We also investigated the DHAR activity, levels of ascorbate, and GSH. Two transgenic plants were successfully developed by Agrobacterium-mediated transformation and were confirmed by PCR and Southern blot analysis. DHAR activity and AsA content in mature leaves of transgenic plants were approximately 1.41 and 1.95 times higher than in the non-transgenic (NT) plants, respectively In addition, the content of oxidized glutathione (GSSG) in transgenic plants was approximately 2.95 times higher than in the NT plants. The ratios of AsA to DHA and GSSG to GSH were changed by overexpression of DHAR, as expected, even though the total content of ascorbate and glutathione was not significantly changed. When tobacco leaf discs were subjected to methyl viologen at $5\;{\mu}M$, $T_0$ transgenic plants showed about a 50% reduction in membrane damage compared to the NT plants.

• Asian-Australasian Journal of Animal Sciences
• /
• 제17권12호
• /
• pp.1641-1646
• /
• 2004

The objective of this study was to generate transgenic mice expressing human resistin gene by using the tetraploidembryonic stem (ES) cell complementation method. Human resistin gene was amplified from human fetal liver cDNA library by PCR, cloned into $pCR^{(R)}$ 2.1 $TOPO^{(R)}$ vector and constructed in pCMV-Tag4C vector. Mammalian expression plasmid containing human resistin was transfected into D3-GL ES cells by Lipofectamine 2,000, and then after 10-12 days of transfection, the human resistin-expressing cells were selected with G418. In order to produce tetraploid embryos, blastomeres of diploid embryos at the two-cell stage were fused with two times of electric pulse using 60 V 30 $\mu$sec (fusion rate: 2,114/2,256, 93.5%) and cultured up to the blastocyst stage (development rate: 1,862/2,114, 94.6%). The selected 15-20 ES cells were injected into tetraploid blastocysts, and then transferred into the uteri of E 2.5 d pseudopregnant recipient mice. To investigate the gestation progress, two E 19.5 mused fetuses were recovered by Cesarean section of which one fetus was confirmed to contain human resistin gene by genomic DNA-PCR. Therefore, our findings demonstrate that tetraploid-ES mouse technology can be considered as a useful tool to produce transgenic mice for the rapid analysis of gene function in vivo.

• 대한수의사회지
• /
• 제23권9호
• /
• pp.603-610
• /
• 1987

The pathological and microbiological studies were carried out to investigate an acute, febrile, highly fetal, infectious disease of rabbits that had occurred in the Winter and in the Spring and that had begun to be reported in Korea from November, 1985. The clinical signs of this disease were characterized by high fever, lethargy, piercing shriek, convulsion, and sudden death with epistaxis, but often they were not observed. The predominant pathogical findings were severe congestion and hamorrhage in trachea, dark brown discoloration of liver by diffuse necrosis or acute viral hepatitis, and hamorrhagic damages of lung, heart, spleen, kidney, etc. The etiological agent was a small round virus, in 25-35nm in diameter and without envelope, thus looking like a picorna virus. This disease resembled what was called the 'Viral Hamorrhagic Pneumonia in Rabbits'(tentative name) that had been reported for the first time in China in 1984. It will be desirable that the disease should be renamed as the 'Viral Hemorrhagic Fever in Rabbits', the 'Acute Viral Hepatitis in Rabbits', etc. because of its charateristics and the basis of pathological findings. An inactivated vaccine is now in the process of preparation for the prophylaxis of this viral disease.

• 약학회지
• /
• 제45권2호
• /
• pp.190-204
• /
• 2001

This study was conducted to investigate for its effects on reproductive and developmental toxicity of recombinant human epidermal growth factor (rhEGF) in Sprague-Dawley rats. Male rats were administered rhEGF at doses of 1, 10, 100, and 1000$\mu$g/kg/day, respective1y, by subcutaneous injection from 63 days before and throughout to mating period until the day before sacrifice. Female rats were administered rhEGF at the same doses from 14 days before mating to day 20 of gestation or to day 21 of lactation. We examined the male and female fertility indices and maternal toxicity of F0 parental animals. Also, we examined the external, visceral, or skeletal malformation of fetuses, growth and development, behavior, and/or reproductive performance of F1 animals. At the highest dose (1,000 $\mu$g/kg), the mean body weights of F0 animals were significantly increased in males and females at 3 or 2 weeks after treatment, respective1y. No clinical signs and food intakes were observed at any time during the experimental period by rhEGF treatment. In autopsy examination, the relative and absolute liver weights significantly increased in both sexes of 1,000 $\mu$g/kg. At the highest dose (1,000 $\mu$g/kg), there was a statistically significant increase of pregnancy period and the number of dead fetuses. Moreover, significant increase of mean fetal body weight and decrease of number of live fetuses, which related to the difficult dilivery were observed in highest dose group. In Fl examination, no adverse effects on external, visceral, and skeletal malformation, physical and functional development, behavior or reproductive ability of Fl animals were observed in any group. Also, there was no significant difference between control and treated groups in copulation or fertility indices of Fl animals. These results indicate that rhEGF had no adverse effect on fertility and reproductive ability of Sprague-Dawley rats.

• Tuberculosis and Respiratory Diseases
• /
• 제61권1호
• /
• pp.70-73
• /
• 2006

우상엽 종괴에 대한 검사 중, 폐암 특히 선암의 암세포 표지인자인 CEA가 증가 되어 있으면서, 간암 및 생식세포 종양의 표지인자인 AFP가 매우 증가되어 있는 원발성 폐암으로 진단된 환자를 경험하여 보고한다.

• Archives of Pharmacal Research
• /
• 제28권4호
• /
• pp.421-432
• /
• 2005

In order to understand the renal reabsorption mechanism of neutral amino acids via amino acid transporters, we have isolated human L-type amino acid transporter 2 (hLAT2) and human T-type amino acid transporter 1 (hTAT1) in human, then, we have examined and compared the gene structures, the functional characterizations and the localization in human kidney. Northern blot analysis showed that hLAT2 mRNA was expressed at high levels in the heart, brain, placenta, kidney, spleen, prostate, testis, ovary, lymph node and the fetal liver. The hTAT1 mRNA was detected at high levels in the heart, placenta, liver, skeletal muscle, kidney, pancreas, spleen, thymus and prostate. Immunohistochemical analysis on the human kidney revealed that the hLAT2 and hTAT1 proteins coexist in the basolateral membrane of the renal proximal tubules. The hLAT2 transports all neutral amino acids and hTAT1 transports aromatic amino acids. The basolateral location of the hLAT2 and hTAT1 proteins in the renal proximal tubule as well as the amino acid transport activity of hLAT2 and hTAT1 suggests that these transporters contribute to the renal reabsorption of neutral and aromatic amino acids in the basolateral domain of epithelial proximal tubule cells, respectively. Therefore, LAT2 and TAT1 play essential roles in the reabsorption of neutral amino acids from the epithelial cells to the blood stream in the kidney. Because LAT2 and TAT1 are essential to the efficient absorption of neutral amino acids from the kidney, their defects might be involved in the pathogenesis of disorders caused by a disruption in amino acid absorption such as blue diaper syndrome.

• 대한수의학회지
• /
• 제34권2호
• /
• pp.361-368
• /
• 1994

기형발생을 나타내는 수은의 독성에 대하여는 이미 보고된 바 있으나 임신중에 폭로된 수은의 독작용을 완화시키거나 치료할 수 있는 제재들에 대하여는 별로 알려진 바가 없다. 수은에 대한 셀레늄의 치료적인 상호작용에 대하여는 이미 보고된바 있으나 태아에 대한 효과를 평가하기 위하여 이 연구는 임신한 CD-1마우스에 20ppm 농도의 유기수은을 음수를 통하여 투여한후 동시에 sodium selenite(체중 kg당 0.1mg, 0.2mg, 0.3mg, 피하주사) 또는 BAL(체중 kg당 5.0mg, 피하주사)을 임신 6일째부터 15일 사이에 단독 또는 병용 투여한 후 임신 18일째에 제왕절개술을 실시하였다. 수은단독 투여군에서는 태아의 체중 및 두부-둔부의 길이 그리고 태반의 무게가 투여를 하지 않은 대조군에 비하여 유의성있게 감소하였고 태아의 사망/재흡수 발생과 기형발생(특히 구개열)이 현저히 증가하였다. 셀레늄과 BAL의 단독 또는 병용투여는 수은에 의하여 발생된 태아에 대한 독작용을 억제하거나 감소시키고 기형발생 역시 유의성있게 감소시켰으나 투여용량 그리고 투여계획과는 특이한 상관관계가 발견되지 않았다. 모체의 수은중독 결과로 보이는 모체의 음수, 사료섭취량과 모체의 상대적 기관(간장, 신장, 비장) 무게의 감소도 셀레늄과 BAL의 투여로 증가되었다. 이 연구 결과는 세레늄을 단독 또는 BAL과 같은 기존치료제와 함께 투여할 경우 수은에 의한 기형발생이나 모체의 아급성 중독 증세를 감소시키거나 완화시킬수 있는 효과가 있음을 보여주고 있다.

• Journal of Yeungnam Medical Science
• /
• 제14권1호
• /
• pp.168-174
• /
• 1997

1993년 1월부터 1996년 9월까지 영남대학교 의과대학 부속병원 산부인과에 내원한 임신 8주에서 41주까지의 정상임산부 500명을 대상으로 혈청 AFP치를 측정하여 다음과 같은 결과를 얻었다. 1. 정상임산부 혈청 AFP치는 임신 8주에 가장 낮았으며, 임신 32주에서 최고치를 나타내었다. 2. 초산부와 경산부의 혈청 AFP평균치는 각각 $166.4{\pm}12.1ng/ml$, $223.8{\pm}14.0ng/ml$ 이었으며, 경산부가 초산부보다 혈청 AFP치가 통계적으로 의의있게 높았다(p<0.01). 3. 정상남아와 정상여아를 분만한 임산부의 혈청 AFP평균치는 각각 $193.0{\pm}13.0ng/ml$, $194.3{\pm}13.8ng/ml$이었으며, 정상남아를 분만한 임산부는 정상 여아를 분만한 임산부와 비교시 혈청 AFP치가 통계적으로 유의한 차이가 없었다(p>0.05). 4. 각 주수에 따른 정상 산모의 혈청 AFP는 표 3과 같다.